QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
DGX$255.63+0.3%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Item | Page | |
|---|---|---|
| Item 1. | Business | 1 |
| Introduction | 1 | |
| Our Strategy | 2 | |
| Our Strengths | 5 | |
| Business Operations | 8 | |
| The Clinical Testing Industry | 10 | |
| General | 18 | |
| Regulation | 22 | |
| Available Information | 25 | |
| Information about Our Executive Officers | 26 | |
| Item 1A. | Risk Factors | 28 |
| Cautionary Factors That May Affect Future Results | 39 | |
| Item 1B. | Unresolved Staff Comments | 42 |
| Item 1C. | Cybersecurity | 42 |
| Item 2. | Properties | 44 |
| Item 3. | Legal Proceedings | 42 |
| Item 4. | Mine Safety Disclosures | 44 |
| Item 5. | Market for Registrant's Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities | 45 |
| Item 6. | Reserved | 46 |
| Item 7. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 46 |
| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk | 47 |
| Item 8. | Financial Statements and Supplementary Data | 47 |
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 47 |
| Item 9A. | Controls and Procedures | 47 |
| Item 9B. | Other Information | 47 |
| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 46 |
| Item 10. | Directors, Executive Officers and Corporate Governance | 49 |
| Item 11. | Executive Compensation | 49 |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholders' Matters | 49 |
| Item 13. | Certain Relationships and Related Transactions, and Director Independence | 49 |
| Item 14. | Principal Accounting Fees and Services | 49 |
| Item 15. | Exhibits, Financial Statement Schedules | 50 |
| Management's Discussion and Analysis of Financial Condition and Results of Operations | 59 | |
| Report of Management on Internal Control Over Financial Reporting | 75 | |
| Report of Independent Registered Public Accounting Firm | F- 1 | |
| Consolidated Financial Statements and Related Notes | F- 3 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.